Rare diseases in healthcare priority setting: should rarity matter?

Rare diseases pose a particular priority setting problem. The UK gives rare diseases special priority in healthcare priority setting. Effectively, the National Health Service is willing to pay much more to gain a quality-adjusted life-year related to a very rare disease than one related to a more co...

Полное описание

Сохранить в:  
Библиографические подробности
Главный автор: Albertsen, Andreas (Автор)
Формат: Электронный ресурс Статья
Язык:Английский
Проверить наличие: HBZ Gateway
Interlibrary Loan:Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany)
Опубликовано: 2022
В: Journal of medical ethics
Год: 2022, Том: 48, Выпуск: 9, Страницы: 624-628
Online-ссылка: Volltext (lizenzpflichtig)
Volltext (lizenzpflichtig)

MARC

LEADER 00000naa a22000002c 4500
001 1918653879
003 DE-627
005 20250226153755.0
007 cr uuu---uuuuu
008 250226s2022 xx |||||o 00| ||eng c
024 7 |a 10.1136/medethics-2020-106978  |2 doi 
035 |a (DE-627)1918653879 
035 |a (DE-599)KXP1918653879 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
100 1 |a Albertsen, Andreas  |e VerfasserIn  |0 (orcid)0000-0001-7528-2493  |4 aut 
245 1 0 |a Rare diseases in healthcare priority setting: should rarity matter? 
264 1 |c 2022 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a Rare diseases pose a particular priority setting problem. The UK gives rare diseases special priority in healthcare priority setting. Effectively, the National Health Service is willing to pay much more to gain a quality-adjusted life-year related to a very rare disease than one related to a more common condition. But should rare diseases receive priority in the allocation of scarce healthcare resources? This article develops and evaluates four arguments in favour of such a priority. These pertain to public values, luck egalitarian distributive justice the epistemic difficulties of obtaining knowledge about rare diseases and the incentives created by a higher willingness to pay. The first is at odds with our knowledge regarding popular opinion. The three other arguments may provide a reason to fund rare diseases generously. However, they are either overinclusive because they would also justify funding for many non-rare diseases or underinclusive in the sense of justifying priority for only some rare diseases. The arguments thus fail to provide a justification that tracks rareness as such. 
773 0 8 |i Enthalten in  |t Journal of medical ethics  |d London : BMJ Publ., 1975  |g 48(2022), 9, Seite 624-628  |h Online-Ressource  |w (DE-627)323607802  |w (DE-600)2026397-1  |w (DE-576)260773972  |x 1473-4257  |7 nnas 
773 1 8 |g volume:48  |g year:2022  |g number:9  |g pages:624-628 
856 4 0 |u https://doi.org/10.1136/medethics-2020-106978  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://jme.bmj.com/content/48/9/624  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4673489527 
LOK |0 003 DE-627 
LOK |0 004 1918653879 
LOK |0 005 20250226153755 
LOK |0 008 250226||||||||||||||||ger||||||| 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 935   |a ixzs  |a ixzo  |a ixrk 
OAS |a 1  |b inherited from superior work 
ORI |a SA-MARC-ixtheoa001.raw